Health - The Purbottar

29 Jun

COVID-19: Mumbai Police Seize Over 7,000 Vehicles

editor0 CommentsHealthmumbai, mumbai police

After issuing a new set of guidelines that restricts the movement of people within a 2-km radius of their homes, the Mumbai police on Monday morning took to social media and revealed that over 7,000 vehicles were seized on June 28. According to the latest post by the Mumbai police, the vehicles have been seized for violating rules of phase-wise unlocking issued by the state government. The police shared a graphical representation of the number of vehicles seized from Zone 1 to Zone 12, including the Port zone and the Traffic Police department. Sharing the picture on Instagram and Twitter, the police…

28 Jun

The closing red light area could save lives in Siliguri

editor0 CommentsHealthCovid19, REDLIGHT, SILIGURI

Siliguri could see a significant surge in COVID-19 cases, hospitalizations, and deaths if the Khalpara Red-Light Area opens, according to a coalition of experts. Extended closure of the red light area could reduce cumulative COVID-19 cases and deaths by over 90% by the peak of the epidemic. The model further projects an additional 54 days of delay in the peak if the Khalpara red light area remains closed. The model was created by experts at Harvard Medical School and the Yale School of Medicine. The model shows that if the Khalpara red-light area starts operating, the disease will spread quickly…

25 Jun

Delhi Among 5 States To Receive First Batch Of COVID-19 Drug

editor0 CommentsHealth

New Delhi: Hyderabad-based drugmaker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi - the two worst affected states in the country. Gujarat and Tamil Nadu are the other two states that will receive the first batch of the drug which is being marketed under the brand name COVIFOR in India. Telangana's capital Hyderabad, where the drugmaker is based, will also receive the first consignment. Hetero has set a target to produce one lakh vials of the drug in two-three weeks. The…

25 Jun

BJP Leaders’ Messages On Twitter Marking 45 Years Of Emergency

editor0 CommentsHealthBJP, EMERGENCY

Emergency in India: BJP leaders today wrote on Twitter to mark 45 years of the Emergency declared by former Prime Minister Indira Gandhi. Several BJP leaders today put out posts on social media to mark 45 years of the Emergency declared by former Prime Minister Indira Gandhi in 1975. Emergency has remained one of the most controversial periods in Indian democracy. The BJP said on Twitter: "Emergency 1975- The unforgivable sin of Congress. Before the President's signature on the declaration papers, top national leaders like JP Narayan, Morarji Desai, LK Advani and AB Vajpayee along with hundreds of others had…

25 Jun

Maharashtra, Delhi Among 5 States To Receive First Batch Of COVID-19 Drug

editor0 CommentsHealthDelhi, Mahar

India, the fourth worst hit nation by the coronavirus, reported a total of 456,183 infections and 14,476 deaths on Wednesday Hyderabad-based drug maker Hetero, which has approval to manufacture and market generic version of Remdesivir, has sent 20,000 vial of the COVID-19 drug to five states, including Maharashtra and Delhi - the two worst affected states in the country. Gujarat and Tamil Nadu are the other two states that will receive the first batch of the experimental COVID-19 drug. Telangana's capital city Hyderabad, where the drugmaker is based, will also receive the first consignment of the drug which is being…

23 Jun

COVID-19: Glenmark receives approval for Favipiravir

editor0 CommentsHealthCovid-19

In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals today announced the launch of antiviral drug Favipiravir (brand name FabiFlu) for the treatment of mild to moderate COVID-19 patients. Glenmark has received manufacturing and marketing approval from India’s drug regulator, making FabiFlu the first oral Favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19. The antiviral offers broad-spectrum RNA virus coverage with clinical improvement noted across age groups 20 to 90 years. Favipiravir can be used in COVID-19 patients with co-morbid…

23 Jun

Ramdev’s Patanjali Launches ‘Coronil’ Anti-Covid Tablets

editor0 CommentsHealth

Patanjali Ayurvedic Medicines has launched 'Coronil' anti-COVID tablets to combat and prevent the spread of the deadly coronavirus. Researched by Patanjali Research Institute with clinical trails held at NIMS University, Jaipur, the anti-corona tablet was launched by Baba Ramdev on Tuesday. Clinical control trials were carried out adhering to standardized protocols of drug discovery to evaluate its efficacy, the company said. Within the span of 3 to 15 days, all the corona positive patients transformed into negative ones without observing any mortality, the company's release about the tablet claims.

23 Jun

Clean Toilets, Colour-coded Dustbins, First Patients on Isolation Coaches Praise Railways

editor0 CommentsHealthindianrailway, Isolation

Clean toilets, colour-coded dustbins, comfortable beds, oxygen cylinders and all amenities one can expect in a top class hospital -- the first inmates of the train coaches converted into isolation wards have come away praising Indian Railways for providing a unique solution to care for suspected COVID-19 patients. "I am used to travelling by trains, but when I entered this one I was taken aback at the sight of the modifications. The stay was comfortable, except for the mosquitoes which were everywhere. The mosquitoes came from under the beds and they should spray repellent under the seats," said Krishnakant Sharma,…

22 Jun

Himanta Biswa Sarma on his Twitter handle mentioned that state’s recovery rate has gone up by 63.2 percent.

editor0 CommentsAssam, Health

GUWAHATI: Assam Health Minister, Himanta Biswa Sarma on his Twitter handle mentioned that state's recovery rate has gone up by 63.2 percent.Meanwhile, in the last 48 hours, 15,000 samples were tested. The total number of samples tested thus far is 2,88,677, the Minister stated.Currently, Assam's COVID-19 positive cases stand at 5,586 of which 3,404 patients have recovered with 2,170 active cases and 9 deaths recorded.

20 Jun

Glenmark launches Covid-19 drug

editor0 CommentsHealth

Glenmark Pharmaceuticals Ltd said on Friday it had received an approval from India's drugs regulator to make and sell oral antiviral drug favipiravir for treating mild-to-moderate COVID-19 patients in the country. The Mumbai-based drugmaker said the approval was part of government's accelerated approval process and the drug would be for "restricted emergency use" in the country. Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014. FabiFlu is the first oral Favipiravir-approved medication for the treatment of Covid-19, the company said in a statement. “This…